About Acarix
Acarix is a company based in Kongens Lyngby (Denmark) founded in 2009. Acarix has raised $9.97 million across 5 funding rounds from investors including SEED Capital, Sunstone and Seventure Partners. The company has 8 employees as of December 31, 2024. Acarix offers products and services including CADScor System and Patient Assessment Patches. Acarix operates in a competitive market with competitors including Conavi, Ionetix, Infraredx, Cleveland HeartLab and Kaminari Medical, among others.
- Headquarter Kongens Lyngby, Denmark
- Employees 8 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Acarix Ab
-
Annual Revenue
$562.1 K (USD)-0.62as on Dec 31, 2024
-
Net Profit
-$6 M (USD)14.97as on Dec 31, 2024
-
EBITDA
-$5.89 M (USD)15.52as on Dec 31, 2024
-
Total Equity Funding
$9.97 M (USD)
in 5 rounds
-
Latest Funding Round
Not available
-
Investors
SEED Capital
& 2 more
-
Employee Count
8
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Acarix
Acarix is a publicly listed company on the OMXSTO with ticker symbol ACARIX in Sweden, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Acarix
Acarix offers a comprehensive portfolio of products and services, including CADScor System and Patient Assessment Patches.
Non-invasive tool for rapid rule-out of significant coronary artery disease.
Components used with CADScor for acoustic blood flow analysis.
People of Acarix
Unlock access to complete
Unlock access to complete
Funding Insights of Acarix
Acarix has successfully raised a total of $9.97M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Acarix
Acarix has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include SEED Capital, Sunstone and Seventure Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm backing Nordic tech startups from seed to Series A with investments in Consumer, Deep Tech, and related sectors.
|
Locked | Locked | Locked | |
|
Investments are made by Sunstone in early-stage European companies.
|
Locked | Locked | Locked | |
|
Tech & Life Sciences focused stage agnostic VC firm investing in Europe, Asia & the US
|
Locked | Locked | Locked |
Investor details for Acarix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Acarix
Investment portfolio details for Acarix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Acarix
Detailed financials for Acarix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Acarix Comparisons
Peer comparison for Acarix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Acarix
Acarix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Conavi, Ionetix, Infraredx, Cleveland HeartLab and Kaminari Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Catheter-based ultrasound systems for cardiac imaging are developed.
|
|
| Locked | Locked | Locked |
Superconducting cyclotrons for PET radioisotopes are developed by Ionetix.
|
|
| Locked | Locked | Locked |
Coronary imaging and plaque detection system
|
|
| Locked | Locked | Locked |
Cardiovascular biomarkers are utilized for disease prevention and management.
|
|
| Locked | Locked | Locked |
Developer of diagnostic solution for vulnerable plaque in the coronary arteries
|
Detailed competitors of Acarix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Acarix
Complete news archive for Acarix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Acarix
Acarix was founded in 2009 and raised its 1st funding round 1 year after it was founded.
Acarix is headquartered in Kongens Lyngby, Denmark. It is registered at Kongens Lyngby, Capital Region, Denmark.
Acarix is a funded company, having raised a total of $9.97M across 5 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Acarix is 8.
Annual revenue of Acarix is $562.1K as on Dec 31, 2024.
Acarix was founded in 2009 and is headquartered in Kongens Lyngby, Denmark. Operations focus on the medical device sector, where an acoustic decision support tool known as the CADScor System is offered. This system aids in diagnosing patients suspected of coronary artery disease through non-invasive acoustic analysis. Services are directed toward healthcare providers seeking early detection methods in cardiology.
Acarix offers CADScor System and Patient Assessment Patches.
Yes, Acarix is publicly traded on OMXSTO under the ticker symbol ACARIX.
Acarix has 3 investors. Key investors include SEED Capital, Sunstone, and Seventure Partners.
The ticker symbol of Acarix is ACARIX on OMXSTO.